NCT06725641

Bioequivalence Study of Methacholine for Inhalation (pharmacodynamics)

Bioequivalence Study of Methacholine for Inhalation

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: China-Japan Friendship Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This trial was divided into two parts. This is the scecond part. The second part is the pharmacodynamic equivalence study of patients, which is a single-dose, randomized, open, two-cycle, two-sequence crossover design, and plans to enroll 40 subjects.

Conditions

• Asthma

Interventions

Type	Name	Description
DRUG	Test preparation：Methylcholine chloroacetate for inhalation	Cholinergic agonists
DRUG	Reference preparation：Methylcholine chloroacetate for inhalation（Provocholine）	Cholinergic agonists

Timeline

• Start date: 2024-02-24
• Primary completion: 2024-10-22
• Completion: 2024-10-26
• First posted: 2024-12-10
• Last updated: 2024-12-10

Locations

1 site across 1 country: China